Rocket One Inc. Deferred Tax Assets, Operating Loss Carryforwards
Rocket One Inc. (RKTO) had Deferred Tax Assets, Operating Loss Carryforwards of $18.65 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $18.65M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $13.39M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.74M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $11.93M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $10.38M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $18.65M 10-K · filed 2026-03-27 | |
| 2024-12-31 | $13.39M 10-K · filed 2026-03-27 | |
| 2023-12-31 | $11.74M 10-K · filed 2025-03-28 | $11.93M 10-K · filed 2024-03-28 |
| 2022-12-31 | $10.38M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $6.75M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $3.34M 10-K · filed 2022-03-30 | |
| 2019-12-31 | $1.98M 10-K · filed 2021-03-16 | |
| 2018-12-31 | $701.78K 10-K · filed 2020-03-02 | |
| 2017-12-31 | $317.70K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |